Ex Vivo TCR αβ T Cell Depletion for Graft-Versus-Host Disease Prophylaxis in Mismatched Donor Peripheral Blood Stem Cell Transplantation for Hematologic Malignancies
Clinical trial NCT03717480 · TERMINATED
Trial details
- NCT number
- NCT03717480
- Sponsor
- Dana-Farber Cancer Institute
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-21
- Primary completion
- 2021-04-26
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.